Canopy Growth (CGC) Times Interest Earned (2019 - 2025)
Canopy Growth (CGC) reported Times Interest Earned of -$2.55 for Q4 2025, down 79.13% on a YoY basis from -$12.2 in Q4 2024, and down 32.61% sequentially from -$1.92 in Q3 2025.
Canopy Growth (CGC) Times Interest Earned (2019 - 2025) Analysis & Trends
Canopy Growth (CGC) has 7 years of Times Interest Earned data on file, last reported at -$2.55 in Q4 2025.
- For the quarter ending Q4 2025, Times Interest Earned fell 79.13% year-over-year to -$2.55; the trailing twelve-month figure through Dec 2025 stood at -$2.11 (up 25.47% YoY), and the FY2026 full-year result was -$0.11, down 34.87% from the prior year.
- Times Interest Earned slipped to -$2.55 in Q4 2025, from -$1.92 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.26 in Q3 2023 to a low of -$68.49 in Q2 2022.
- A 5-year average of -$10.86 and a median of -$3.39 in 2022 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned soared 98.94% in 2021 and plunged 796.25% in 2022, its largest moves.
- Tracing CGC's Times Interest Earned over 5 years: stood at -$5.68 in 2021, then jumped by 40.38% to -$3.39 in 2022, then gained by 27.65% to -$2.45 in 2023, then jumped by 42.0% to -$1.42 in 2024, then slumped by 79.13% to -$2.55 in 2025.
- Business Quant data shows CGC's Times Interest Earned at -$2.55 in Q4 2025, -$1.92 in Q3 2025, and -$2.32 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.55 |
| Sep 30, 2025 | -1.92 |
| Jun 30, 2025 | -2.32 |
| Dec 31, 2024 | -1.42 |
| Sep 30, 2024 | -2.16 |
| Jun 30, 2024 | -1.38 |
| Mar 31, 2024 | -7.68 |
| Dec 31, 2023 | -2.45 |
| Sep 30, 2023 | -0.26 |
| Jun 30, 2023 | -1.70 |
| Mar 31, 2023 | -17.64 |
| Dec 31, 2022 | -3.39 |
| Sep 30, 2022 | -4.90 |
| Jun 30, 2022 | -68.49 |
| Mar 31, 2022 | -17.69 |
| Dec 31, 2021 | -5.68 |
| Sep 30, 2021 | -8.08 |
| Jun 30, 2021 | -7.64 |
| Mar 31, 2021 | -49.08 |
| Dec 31, 2020 | -537.49 |